DAPAGLIFLOZIN

UNII:	1ULL0QJ8UC
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₁H₂₅ClO₆
Preferred Substance Name:	DAPAGLIFLOZIN
InChIKey:	JVHXJTBJCFBINQ-ADAARDCZSA-N
GSRS Full Record:	1ULL0QJ8UC i

461432-26-8
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
BMS-512148
BR1019 component Dapagliflozin
D-GLUCITOL, 1,5-ANHYDRO-1-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-, (1S)-
DAPAGLIFLOZIN COMPONENT QTERNMET
DAPAGLIFLOZIN [MI]
DAPAGLIFLOZIN [ORANGE BOOK]
DAPAGLIFLOZIN [USAN]
DAPAGLIFLOZIN [VANDF]
Dapagliflozin
Dapagliflozin [WHO-DD]
LYN-045
QTERNMET COMPONENT DAPAGLIFOZIN
QTERNMET XR COMPONENT DAPAGLIFLOZIN
dapagliflozin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DAPAGLIFLOZIN

Synonyms and Mappings

Resources